Today: 25 April 2026
Saudi Aramco (Saudi Arabian Oil Co) stock falls 2.4% as Saudi shares slide on Iran risk
1 February 2026
1 min read

Saudi Aramco (Saudi Arabian Oil Co) stock falls 2.4% as Saudi shares slide on Iran risk

Riyadh, Feb 1, 2026, 17:33 GMT+3 — The market has closed.

Shares of Saudi Arabian Oil Co (2222) fell 2.4%, ending Sunday at 25.18 riyals. Trading volume hit roughly 9.5 million shares on the Saudi Exchange.

Saudi Arabia’s benchmark index (TASI, the Tadawul All Share Index) dropped 1.9%, marking its steepest intraday decline since April. The slide came amid rising concerns over potential U.S. military action against Iran. Ayatollah Ali Khamenei warned that any American strike would spark a regional conflict. Meanwhile, Washington has bolstered its naval forces following repeated warnings from Donald Trump, the report said.

This is significant for Aramco, as it ranks among the market’s largest components and a crucial dividend provider for local investors. When risk appetite falls in the region, the stock tends to move more on sentiment than on crude oil fundamentals.

Oil is charting its own course. OPEC+ — led by Saudi Arabia and Russia — has tentatively agreed to maintain current output levels through March, according to a draft statement and sources who spoke with Reuters. Eight core members are set to meet later Sunday to finalize the decision. Brent crude ended Friday just shy of $70 a barrel, near the six-month peak of $71.89 touched the day before, despite ongoing debate over whether an oversupply in 2026 might weigh on prices.

On Feb. 1, Aramco’s shares fluctuated from 25.16 to 25.78 riyals, according to Investing.com. The stock’s 52-week range stands at 23.04 to 27.85.

Some investors are closely tracking whether the new foreign-access rules will impact the flow of capital immediately or remain largely theoretical. “This rally comes ahead of foreign participation,” Hamad Al-Olayan, CEO of Villa Capital, told Asharq Al-Awsat. Mohamed Hamdy Omar, CEO of G World, described the change as “a historic step.” Aawsat

The next moves remain unpredictable. Signs of easing tensions between Washington and Tehran might strip oil of its geopolitical premium, weakening support for Aramco. On the other hand, any escalation could keep regional equities under strain, even if crude prices stay steady.

Monday’s session will center on the OPEC+ decision and how oil prices respond, with traders also watching weekend headlines about U.S.-Iran tensions. Early indications on whether foreign investors step up or hold back will be key.

Aramco’s next major event is its full-year 2025 results, scheduled for March 10, per the company’s financial calendar. Investors are closely watching that date for dividend cues and other key updates.

update on spending plans.

Stock Market Today

  • Bitcoin $40,000 Bear Case Would Be Historic Outlier, Analyst Says
    April 25, 2026, 12:47 PM EDT. Bitcoin has gained nearly 15% this month, trading near $78,000, but remains 40% below its all-time high. Some forecasters predict a drop to $40,000, a 70% decline from its peak. Analyst James Check calls this scenario highly unlikely, labeling it a "0.4 event" on his Bitcoin Mean Reversion Index-a composite valuation model. Such a drop would rank in the 0.4th percentile historically, a rarity comparable to Bitcoin trading below $2 in 2011. Currently, Bitcoin's price sits at the 31.5th percentile, indicating weakness but still within normal correction ranges. Check warns the $40,000 prediction is near unprecedented in market history, underscoring the improbability of such a deep plunge.

Latest article

Shake Shack Stock Gets a Fresh Wall Street Boost Before Earnings. Here’s What Changed

Shake Shack Stock Gets a Fresh Wall Street Boost Before Earnings. Here’s What Changed

25 April 2026
Guggenheim initiated Shake Shack at Buy with a $120 price target, citing margin upside and expansion potential. Shares rose 5.6% to $103.02. The call comes ahead of Shake Shack’s May 7 earnings report, with recent data showing first-quarter visits up nearly 20% year-over-year. JPMorgan raised its target to $100 but kept a Neutral rating, reflecting mixed analyst sentiment.
CRISPR Therapeutics Stock Just Lost 12%: What Casgevy Must Prove Next

CRISPR Therapeutics Stock Just Lost 12%: What Casgevy Must Prove Next

25 April 2026
CRISPR Therapeutics shares fell 11.6% Friday, closing at $48.79 with no new company disclosures. The company reported $116 million in 2025 Casgevy revenue and ended the year with $1.98 billion in cash. A June 4 shareholder meeting will vote on expanding the capital band and carrying forward a CHF 1.89 billion net loss. In March, CRISPR raised $536.3 million from a convertible notes offering.
Intellia Therapeutics Stock Jumps After Hours Ahead of First Phase 3 In Vivo CRISPR Readout

Intellia Therapeutics Stock Jumps After Hours Ahead of First Phase 3 In Vivo CRISPR Readout

25 April 2026
Intellia Therapeutics will release Phase 3 data Monday from its HAELO trial of lonvoguran ziclumeran, an in vivo CRISPR gene-editing therapy for hereditary angioedema. The study enrolled 80 patients, testing a single 50 mg infusion against placebo. Intellia shares rose 19.3% after hours Friday ahead of the announcement. The company ended 2025 with $605.1 million in cash and expects it to last into late 2027.
ArcBest stock price jumped after a brutal earnings swing — what to watch next week
Previous Story

ArcBest stock price jumped after a brutal earnings swing — what to watch next week

Amazon stock (AMZN) heads into earnings week as Saks ends “Saks on Amazon” deal
Next Story

Amazon stock (AMZN) heads into earnings week as Saks ends “Saks on Amazon” deal

Go toTop